Working… Menu

A Protocol for the Use of Chlorhexidine Gluconate Saturation for the Reduction of Dental Biofilm Formation on Polymethylmethacrylate Restoration

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00259181
Recruitment Status : Completed
First Posted : November 29, 2005
Last Update Posted : January 6, 2010
Information provided by:
Hadassah Medical Organization

Brief Summary:
Chlorhexidine gluconate (CHX), as an anti plaque agent, is commonly used with a variety of products. In this study we, the investigators at Hadassah Medical Organization, intend to examine the efficacy of a single dip in CHX of provisional restoration prior to oral cementation. If the protocol is effective, we intend to calibrate it and recommend clinical use of the protocol. The examination of biofilm formation will be both with electron microscope and confocal scanning laser microscope.

Condition or disease Intervention/treatment Phase
Dental Plaque Procedure: saturation of polymethylmethacrylate with chlorhexidine gluconate to reduce in vivo plaque formation Phase 1

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Enrollment : 12 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: Single
Primary Purpose: Prevention
Official Title: Examination of the Immersion of Provisional Crown Material in Chlorhexidine Gluconate on Dental Plaque Formation in Vivo
Study Start Date : January 2005

Primary Outcome Measures :
  1. calibration of a preventative protocol for biofilm formation measured by confocal scanning laser microscope and scanning electron microscope

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   Child, Adult, Older Adult
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes

Inclusion Criteria:

  • Any volunteer without systemic condition

Exclusion Criteria:

  • Intake of antibiotic drug three months prior to experiment

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its identifier (NCT number): NCT00259181

Layout table for location information
Hadassah Medical Organization
Jerusalem, Israel, 91120
Sponsors and Collaborators
Hadassah Medical Organization
Layout table for investigator information
Study Director: Michael M Perez Davidi, DMD Hadassah Medical Organization
Additional Information:
Layout table for additonal information Identifier: NCT00259181    
Other Study ID Numbers: 191058HMO-CTIL
First Posted: November 29, 2005    Key Record Dates
Last Update Posted: January 6, 2010
Last Verified: December 2007
Keywords provided by Hadassah Medical Organization:
chlorhexidine gluconate
Anti-Bacterial Agents
Additional relevant MeSH terms:
Layout table for MeSH terms
Dental Plaque
Dental Deposits
Tooth Diseases
Stomatognathic Diseases
Chlorhexidine gluconate
Polymethyl Methacrylate
Anti-Infective Agents, Local
Anti-Infective Agents
Dermatologic Agents
Vasodilator Agents
Antimutagenic Agents
Protective Agents
Physiological Effects of Drugs